Israel Large Molecule Drug Substance CDMO Market (2025-2031) | Outlook, Competitive Landscape, Analysis, Value, Size & Revenue, Industry, Forecast, Share, Trends, Segmentation, Companies, Growth

Name: Israel Large Molecule Drug Substance CDMO Market (2025-2031) | Outlook & Competitive Landscape
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Service (Contract Manufacturing, Clinical, Commercial, Contract Development, Cell Line Development, Process Development), By Source (Mammalian, Microbial, Others), By End-user (Biotech Companies, CRO, Others) And Competitive Landscape

Product Code: ETC7654606	Publication Date: Sep 2024	Updated Date: Nov 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Vasudha	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Israel Large Molecule Drug Substance Cdmo Market Top 5 Importing Countries and Market Competition (HHI) Analysis

In 2024, Israel continued to rely heavily on imports of large molecule drug substances from top exporting countries such as Switzerland, USA, Germany, China, and Belgium. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, with limited diversification in sourcing. Despite a negative compound annual growth rate (CAGR) from 2020-24, there was a notable improvement in the growth rate from 2023-24, suggesting a potential shift in the market dynamics and increasing demand for large molecule drug substances in Israel.

Israel Large Molecule Drug Substance Cdmo Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

Israel Large Molecule Drug Substance CDMO Market Outlook
Market Size of Israel Large Molecule Drug Substance CDMO Market, 2024
Forecast of Israel Large Molecule Drug Substance CDMO Market, 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Revenues & Volume for the Period 2021- 2031
Israel Large Molecule Drug Substance CDMO Market Trend Evolution
Israel Large Molecule Drug Substance CDMO Market Drivers and Challenges
Israel Large Molecule Drug Substance CDMO Price Trends
Israel Large Molecule Drug Substance CDMO Porter's Five Forces
Israel Large Molecule Drug Substance CDMO Industry Life Cycle
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Service for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Contract Manufacturing for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Clinical for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Commercial for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Contract Development for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Cell Line Development for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Process Development for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Source for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Mammalian for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Microbial for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By End-user for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Biotech Companies for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By CRO for the Period 2021- 2031
Historical Data and Forecast of Israel Large Molecule Drug Substance CDMO Market Revenues & Volume By Others for the Period 2021- 2031
Israel Large Molecule Drug Substance CDMO Import Export Trade Statistics
Market Opportunity Assessment By Service
Market Opportunity Assessment By Source
Market Opportunity Assessment By End-user
Israel Large Molecule Drug Substance CDMO Top Companies Market Share
Israel Large Molecule Drug Substance CDMO Competitive Benchmarking By Technical and Operational Parameters
Israel Large Molecule Drug Substance CDMO Company Profiles
Israel Large Molecule Drug Substance CDMO Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Israel Large Molecule Drug Substance CDMO Market Overview

3.1 Israel Country Macro Economic Indicators

3.2 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F

3.3 Israel Large Molecule Drug Substance CDMO Market - Industry Life Cycle

3.4 Israel Large Molecule Drug Substance CDMO Market - Porter's Five Forces

3.5 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F

3.6 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F

3.7 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F

4 Israel Large Molecule Drug Substance CDMO Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for biologics and large molecule drugs in the pharmaceutical industry

4.2.2 Growing trend towards outsourcing manufacturing activities to contract development and manufacturing organizations (CDMOs)

4.2.3 Technological advancements in the production of large molecule drug substances

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and compliance standards for large molecule drug manufacturing

4.3.2 High initial capital investment and operational costs associated with setting up large molecule drug manufacturing facilities

5 Israel Large Molecule Drug Substance CDMO Market Trends

6 Israel Large Molecule Drug Substance CDMO Market, By Types

6.1 Israel Large Molecule Drug Substance CDMO Market, By Service

6.1.1 Overview and Analysis

6.1.2 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F

6.1.3 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F

6.1.4 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F

6.1.5 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F

6.1.6 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F

6.1.7 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F

6.1.8 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F

6.2 Israel Large Molecule Drug Substance CDMO Market, By Source

6.2.1 Overview and Analysis

6.2.2 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F

6.2.3 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F

6.2.4 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F

6.3 Israel Large Molecule Drug Substance CDMO Market, By End-user

6.3.1 Overview and Analysis

6.3.2 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F

6.3.3 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F

6.3.4 Israel Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F

7 Israel Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics

7.1 Israel Large Molecule Drug Substance CDMO Market Export to Major Countries

7.2 Israel Large Molecule Drug Substance CDMO Market Imports from Major Countries

8 Israel Large Molecule Drug Substance CDMO Market Key Performance Indicators

8.1 Percentage increase in the number of partnerships between pharmaceutical companies and CDMOs for large molecule drug manufacturing

8.2 Average turnaround time for large molecule drug substance production

8.3 Rate of adoption of innovative manufacturing technologies in large molecule drug production

8.4 Number of new entrants or expansions in the Israel large molecule drug substance CDMO market

8.5 Level of investment in research and development for improving manufacturing processes and capabilities in the market

9 Israel Large Molecule Drug Substance CDMO Market - Opportunity Assessment

9.1 Israel Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F

9.2 Israel Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F

9.3 Israel Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F

10 Israel Large Molecule Drug Substance CDMO Market - Competitive Landscape

10.1 Israel Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024

10.2 Israel Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Large Molecule Drug Substance CDMO Market

Global Large Molecule Drug Substance CDMO Market

Middle East Large Molecule Drug Substance CDMO Market

North America Large Molecule Drug Substance CDMO Market

Uruguay Large Molecule Drug Substance CDMO Market

Uzbekistan Large Molecule Drug Substance CDMO Market

Vanuatu Large Molecule Drug Substance CDMO Market

Yemen Large Molecule Drug Substance CDMO Market

Zambia Large Molecule Drug Substance CDMO Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here